Loading company
Biolife Solutions Inc.
BLFS · Nasdaq · Healthcare · Medical Instruments and Supplies
A+
$38.61+3.5%Oct 5 close
Figures through June 30, 2026, from the 10-Q filed August 6, 2026
Past performance
- 3M
- +10.1%
- 6M
- +83.3%
- 1Y
- +60.4%
- 5Y
- -20.9%
BLFS · Nasdaq · Healthcare · Medical Instruments and Supplies
$38.61+3.5%Oct 5 close
Figures through June 30, 2026, from the 10-Q filed August 6, 2026
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $28.5M | $23.4M | +21.45% |
| Profit | $45.1M | -$15.8M | +384.78% |
| Profit per share | $0.91 | -$0.33 | +375.76% |
| Free Cash Flow | $5.3M | $1.3M | +298.87% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Biolife Solutions Inc. has no earnings call transcript available.
“We delivered another strong quarter, with solid execution across the business led by our market-leading biopreservation media franchise,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
BioLife is a leading developer and supplier of cell processing tools and services for the CGT market. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during the collection, development, Page 3 manufacturing and distribution.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Biolife Solutions Inc.’s Item 2.02 8-K filed August 6, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.